A novel recombinant tumor necrosis factor-alpha mutant with increased anti-tumor activity and lower toxicity
- 9 July 1991
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 48 (5) , 744-748
- https://doi.org/10.1002/ijc.2910480519
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Induction of differentiation of human monoblastic and myeloblastic leukemia cell lines by TNF muteinsBiochemical and Biophysical Research Communications, 1989
- Production of the human immunoglobulin γ1 chain constant region polypeptides in Escherichia coliJournal of Biotechnology, 1988
- The antitumor function of tumor necrosis factor (TNF), I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity.The Journal of Experimental Medicine, 1988
- Phase I study of recombinant human tumor necrosis factorCancer Chemotherapy and Pharmacology, 1987
- Cachectin and tumour necrosis factor as two sides of the same biological coinNature, 1986
- Identity of tumour necrosis factor and the macrophage-secreted factor cachectinNature, 1985
- Lipoprotein lipase suppression in 3T3-L1 cells by an endotoxin-induced mediator from exudate cells.Proceedings of the National Academy of Sciences, 1982
- Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycolurilBiochemical and Biophysical Research Communications, 1978
- An endotoxin-induced serum factor that causes necrosis of tumors.Proceedings of the National Academy of Sciences, 1975
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970